Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in bran ...

Terumo Aortic announced enrollment of the first patient in the fenestrated TREO pivotal trial in the United States. Accordi ...

Neurotronic, Inc. announced the first clinical outcomes of the NECTAR III and NECTAR IV trials evaluating the company’s ...

Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the ...

Vesalio announced two FDA 510(k) clearances for its aspiration devices for peripheral and neurovascular applications, ...

RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial ...

Experts share advice for junior colleagues before their first case, including basic keys to success and pitfall avoidance, what to watch for when observing a case, and questions to ask and when to ask ...

Insights from PERT/DVT, limb salvage, and aortic team members on effective networking that lasts longer than the launch ...

Understanding the hazards of radiation and the importance of physical health in the endovascular suite and cath lab, and what ...

November 12, 2025—ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. According to the company, AiORTA Plan is a fully automated, ...

November 12, 2025—CUC Inc., a provider of health care management and operational support services headquartered in Tokyo, Japan, announced it has signed a Memorandum of Understanding (MOU) with Yuji ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.